U.S. market Closed. Opens in 1 hour 9 minutes

HCWB | HCW Biologics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue2.84M6.72MN/A4.10MN/A
Cost of Revenue3.42M4.14M543.60KN/A421.82K
Gross Profit-574.82K2.59M-543.60K4.10M-421.82K
Operating Expenses25.14M17.67M13.37M9.92M7.37M
Selling, General & Admin18.01M8.33M4.98M2.44M1.80M
Research & Development7.13M9.34M8.17M7.26M5.39M
Other Operating Expenses1.01M304.74K218.47K233.04K171.42K
Operating Income-25.72M-15.08M-13.37M-5.82M-7.37M
Other Expenses / Income722.88K178.07K505.37K22.32K72.35K
Before Tax Income-24.99M-14.90M-12.86M-5.80M-7.29M
Income Tax Expenses-4.00-178.07K-505.37K-22.32K-72.35K
Net Income-24.99M-14.72M-12.36M-5.78M-7.22M
Interest Expenses283.04K126.66KN/AN/AN/A
Basic Shares Outstanding35.93M35.82M35.77M36.70M36.70M
Diluted Shares Outstanding35.93M35.82M35.77M36.70M36.70M
EBITDA-24.58M-14.77M-12.82M-5.23M-6.94M
EBITDA Margin-865.02%-219.78%0.00%-127.53%0.00%
EBIT-24.71M-14.77M-12.86M-5.80M-7.29M
EBIT Margin-869.56%-219.78%0.00%-141.53%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙